Literature DB >> 36191323

Incidence of Myocarditis/Pericarditis Following mRNA COVID-19 Vaccination Among Children and Younger Adults in the United States.

Kristin Goddard1, Kayla E Hanson2, Ned Lewis1, Eric Weintraub3, Bruce Fireman1, Nicola P Klein1.   

Abstract

Entities:  

Year:  2022        PMID: 36191323      PMCID: PMC9578536          DOI: 10.7326/M22-2274

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   51.598


× No keyword cloud information.
  3 in total

1.  Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.

Authors:  Matthew E Oster; David K Shay; John R Su; Julianne Gee; C Buddy Creech; Karen R Broder; Kathryn Edwards; Jonathan H Soslow; Jeffrey M Dendy; Elizabeth Schlaudecker; Sean M Lang; Elizabeth D Barnett; Frederick L Ruberg; Michael J Smith; M Jay Campbell; Renato D Lopes; Laurence S Sperling; Jane A Baumblatt; Deborah L Thompson; Paige L Marquez; Penelope Strid; Jared Woo; River Pugsley; Sarah Reagan-Steiner; Frank DeStefano; Tom T Shimabukuro
Journal:  JAMA       Date:  2022-01-25       Impact factor: 157.335

2.  Surveillance for Adverse Events After COVID-19 mRNA Vaccination.

Authors:  Nicola P Klein; Ned Lewis; Kristin Goddard; Bruce Fireman; Ousseny Zerbo; Kayla E Hanson; James G Donahue; Elyse O Kharbanda; Allison Naleway; Jennifer Clark Nelson; Stan Xu; W Katherine Yih; Jason M Glanz; Joshua T B Williams; Simon J Hambidge; Bruno J Lewin; Tom T Shimabukuro; Frank DeStefano; Eric S Weintraub
Journal:  JAMA       Date:  2021-10-12       Impact factor: 56.272

3.  Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination.

Authors:  Kristin Goddard; Ned Lewis; Bruce Fireman; Eric Weintraub; Tom Shimabukuro; Ousseny Zerbo; Thomas G Boyce; Matthew E Oster; Kayla E Hanson; James G Donahue; Pat Ross; Allison Naleway; Jennifer C Nelson; Bruno Lewin; Jason M Glanz; Joshua T B Williams; Elyse O Kharbanda; W Katherine Yih; Nicola P Klein
Journal:  Vaccine       Date:  2022-07-12       Impact factor: 4.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.